Kaneka (4118) AI Stock Analysis

• Market Cap: ¥333.27B
• Dividend Yield: 3.41%
• Average Volume (3M): 189.42K
• Price to Earnings (P/E): 12.6
• Beta (1Y): 0.83
• Revenue Growth: 2.60%
• EPS Growth: 9.50%
• Country: JP
• Employees: 11,544
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 120.21
• Shares Outstanding: 66,000,000
• 10 Day Avg. Volume: 277,740
• 30 Day Avg. Volume: 189,416
• PEG Ratio: 0.77
• Price to Book (P/B): 0.51
• Price to Sales (P/S): 0.30
• P/FCF Ratio: -24.21
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥4,837.70
• Price Target Upside: -8.36% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 4
• EPS Forecast (FY): 493.55
• Revenue Forecast (FY): ¥810.82B

• Rating: 74 Outperform
• Price Target: ¥5,902.00 ▲(11.80% Upside)
• Action: Upgraded Date: 11/01/25
• Date: Action: Upgraded 11/01/25

Kaneka's stock is supported by strong valuation metrics and stable technical indicators. Financial performance shows robust revenue growth and operational efficiency, though profitability and cash flow challenges need addressing. The absence of earnings call and corporate events data limits further insights.

Positive Factors

Diversified Business Model

Kaneka's breadth across chemicals, specialty materials and life-science products reduces exposure to any single cyclic end market. This multi-segment footprint supports steadier revenue through cycles, enables cross-selling, and preserves long-term resilience as different end-markets decouple.

Sustained Revenue Growth & Efficiency

Consistent mid-single-digit CAGR and reported improvements in gross and operating margins indicate the business can scale while maintaining unit economics. Durable top-line growth coupled with rising EBIT/EBITDA margins signals competitive positioning and operational improvements that support sustainable profitability.

Solid Operating Cash Generation and Equity Base

Robust operating cash flow demonstrates core cash-generation capacity to fund working capital and some investments. A rising equity base and an improved equity ratio (~51.3%) provide balance-sheet resilience and financial flexibility to support strategic investments and absorb cyclical shocks over the medium term.

Negative Factors

Negative Free Cash Flow

Sustained negative free cash flow driven by heavy capex is structurally important: it constrains internal funding for dividends, R&D or acquisitions, and increases dependence on external financing. Over months this can pressure liquidity and limit strategic optionality if capex persists.

Declining Net Profit Margin

A declining net margin despite stable gross margins suggests rising operating, financing, or non-operational costs that erode earnings retention. Persistently low single-digit net margins reduce retained earnings and make the company more sensitive to cost shocks, limiting long-term reinvestment ability.

Rising Debt Levels

An increasing debt stock and higher leverage, even if moderate today, raises interest and refinancing risk over time. If earnings or cash generation weaken, servicing higher debt could force cutbacks or costly refinancing, constraining strategic moves and increasing financial vulnerability in adverse scenarios.

Kaneka Business Overview & Revenue Model

Company Description

Kaneka Corporation manufactures and sells polyvinyl chloride (PVC), crosslinked PVC, PVC-PVAc polymers, paste PVC, acryl grafted-vinyl chloride copolymer, and chlorinated PVC in Japan and internationally. It provides impact modifiers, processing aids, specialty additives, toughener for thermosetting resins, silyl-terminated polyether, acrylic silicon, terminally reactive liquid acrylic, and biodegradable polymer, engineering resin for injection molding, zero birefringence, acrylic film, and isobutylene-based thermoplastic elastomer products. The company also offers polypropylene and kanelite foams, extruded polystyrene foam insulation, polyimide film, transparent film for optical use, high thermal conductive graphite sheets, multi-layer insulation, transparent conductive film, and thermo-resistant, and light-resistant transparent resin products. In addition, it provides photovoltaic power generation systems for residences, public, and industrial installations; eco fur, flame-retardant, hair accessory, and new materials; organic EL lighting panels; and biosurfactant. Further, the company offers intervention, blood purification, gastroenterology intervention, testing equipment, regenerative medicine and cell therapy, and genetic diagnostic products; and low molecular pharmaceutical materials, affinity chromatography resin for purification of a monoclonal antibody, biopharmaceuticals, transdermal medicine, and innerwear with shock-absorbing pad. It also provides dairy products, margarine, fat and oils, whipping cream, filling, baker's yeast/ dough improver, processed fruits, butter, shortening, cacao butter alternatives, cream for kneading and other uses, frozen dough, spices, antifreeze materials; and pharma and supplemental nutrition solutions, including coenzyme, lactic-acid bacteria, and functional foodstuffs, as well as fertilizers. Kaneka Corporation was incorporated in 1949 and is headquartered in Tokyo, Japan.

How the Company Makes Money

Kaneka generates revenue through multiple key streams, primarily from the sale of its specialty chemicals, which are used in a wide range of industries, including electronics, automotive, and construction. The company's pharmaceutical division contributes significantly to its earnings through the development and commercialization of prescription drugs and medical products. Additionally, Kaneka has established partnerships with various firms and research institutions to enhance its product offerings and expand its market reach, which further supports its revenue growth. The company also invests in biotechnology and health-related sectors, generating income through the sale of health supplements and functional foods.

Kaneka Financial Statement Overview

Summary

Kaneka demonstrates solid revenue growth and operational efficiency, supported by stable equity and robust operating cash flows. However, challenges persist in the form of declining net profit margins and negative free cash flow, largely driven by significant capital expenditures. The increase in debt levels requires careful monitoring to ensure financial stability.

Income Statement

Kaneka's income statement shows strong revenue growth with a compound annual growth rate (CAGR) of approximately 6.4% over the past five years. The gross profit margin has been relatively stable, with a slight improvement to 27.8% in 2025. However, the net profit margin shows a slight decline from previous periods, standing at 3.1% for 2025. EBIT and EBITDA margins have improved, indicating operational efficiency, but the declining net profit margin signals pressure on the bottom line, possibly due to increased expenses or cost of goods sold.

Balance Sheet

Kaneka's balance sheet indicates a stable equity position, with stockholders' equity rising to 471,937 million yen in 2025. The debt-to-equity ratio increased to 0.47, showing a moderate leverage level. The equity ratio improved slightly to 51.3%, suggesting a robust financial position. However, the rise in total debt over the years could pose potential risks if not managed carefully. Overall, the company maintains a balanced approach to leveraging debt while sustaining equity growth.

Cash Flow

The cash flow statement reveals challenges in free cash flow, which turned negative in 2025 at -9,931 million yen, due to high capital expenditures. Operating cash flow remains strong at 41,252 million yen, indicating good cash generation from core operations. The free cash flow to net income ratio is negative due to the capital intensity, but the operating cash flow to net income ratio stands favorably. While cash from operations is solid, the negative free cash flow suggests a need for careful capital management to avoid liquidity issues.

Breakdown	TTM	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Income Statement
Total Revenue	807.50B	807.20B	762.30B	755.82B	691.53B	577.43B
Gross Profit	223.41B	224.63B	204.22B	198.93B	196.65B	166.94B
EBITDA	73.88B	84.74B	81.62B	74.44B	75.98B	60.27B
Net Income	22.54B	25.31B	23.22B	23.01B	26.49B	15.83B
Balance Sheet
Total Assets	920.22B	920.14B	870.21B	782.64B	726.96B	667.43B
Cash, Cash Equivalents and Short-Term Investments	44.35B	45.64B	43.97B	41.87B	41.95B	47.92B
Total Debt	212.31B	223.06B	195.09B	175.94B	132.83B	119.34B
Total Liabilities	428.71B	427.72B	395.82B	346.22B	314.76B	286.39B
Stockholders Equity	470.63B	471.94B	454.11B	417.99B	387.77B	357.61B
Cash Flow
Free Cash Flow	0.00	-9.93B	-3.35B	-13.28B	-5.82B	31.64B
Operating Cash Flow	0.00	41.25B	61.91B	28.71B	34.11B	74.04B
Investing Cash Flow	0.00	-55.04B	-58.77B	-41.97B	-39.59B	-43.23B
Financing Cash Flow	0.00	14.45B	-1.52B	12.35B	-1.10B	-21.90B

Kaneka Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5279.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4118, the sentiment is Positive. The current price of 5279 is above the 20-day moving average (MA) of 5022.30, above the 50-day MA of 4732.84, and above the 200-day MA of 4274.59, indicating a bullish trend. The MACD of 137.51 indicates Negative momentum. The RSI at 76.85 is Negative, neither overbought nor oversold. The STOCH value of 84.96 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4118.

Kaneka Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4202	80 Outperform	¥426.73B	10.54	9.34%	4.27%	-0.48%	-35.29%
4118	74 Outperform	¥333.27B	12.62	5.47%	3.41%	2.60%	9.50%
6988	68 Neutral	¥2.30T	18.48	11.98%	1.54%	1.84%	-6.57%
4631	65 Neutral	¥437.69B	12.96	8.14%	2.61%	-1.45%	―
4208	65 Neutral	¥278.10B	7.93	1.47%	4.29%	-7.45%	-71.68%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
4183	61 Neutral	¥913.33B	52.39	2.02%	3.82%	-4.63%	-65.11%

Kaneka Corporate Events

Kaneka Nears Completion of ¥12 Billion Share Buyback Program

Kaneka Corporation has reported the latest status of its ongoing share repurchase program authorized by its board in May 2025, which allows buybacks of up to 3 million shares or ¥12 billion through market purchases on the Tokyo Stock Exchange between May 15, 2025 and March 24, 2026. As part of this program, the company bought 240,500 shares for about ¥1.22 billion during February 2026, bringing total repurchases to 2,404,500 shares and approximately ¥10.5 billion by the end of that month, signaling continued capital return to shareholders and active balance sheet management.

These transactions indicate Kaneka has utilized most of its authorized buyback capacity ahead of the March 2026 deadline, which may support its share price, improve capital efficiency, and slightly increase earnings per share through a reduced share count. The scale and pace of the repurchases underscore management’s confidence in the company’s valuation and its focus on shareholder returns, while leaving some remaining headroom under the existing authorization for potential further buybacks before the program’s scheduled end.

The most recent analyst rating on (JP:4118) stock is a Buy with a Yen5912.00 price target. To see the full list of analyst forecasts on Kaneka stock, see the JP:4118 Stock Forecast page.

Kaneka Posts Lower Nine-Month Earnings but Lifts Full-Year Dividend Outlook

Kaneka reported consolidated net sales of ¥598.3 billion for the nine months ended December 31, 2025, down 0.8% year on year, with operating income falling 23.8% to ¥22.2 billion and ordinary income down 26.1%. Despite weaker profitability, net income attributable to owners of the parent inched up 4.0% to ¥18.4 billion, while total assets rose to ¥953.5 billion and the equity ratio stayed broadly stable at just above 50%.

The company maintained its full-year outlook of slightly lower sales at ¥800 billion and expects double-digit declines in operating and ordinary income, but projects a 24.5% rise in full-year net income to ¥31.5 billion. Kaneka also plans to raise its annual dividend to ¥160 per share for the fiscal year ending March 31, 2026, signaling continued shareholder returns even as earnings pressure persists and treasury stock holdings increase.

The most recent analyst rating on (JP:4118) stock is a Buy with a Yen5552.00 price target. To see the full list of analyst forecasts on Kaneka stock, see the JP:4118 Stock Forecast page.

Kaneka Issues Cautionary Financial Summary for Nine Months to December 2025

Kaneka disclosed a financial summary document for the nine months ended December 31, 2025, dated February 10, 2026, outlining results, segment performance, balance sheets, earnings forecasts, and corporate topics. The release emphasizes that all projections are forward-looking, based on currently available information, and cautions that actual results may differ substantially, with the Japanese original prevailing over this English translation.

The company positions the document as a reference tool for stakeholders to understand recent financial performance and expectations while explicitly disavowing any guarantee that forecasted operating results will be achieved. By stressing translation precedence and uncertainty around forward-looking statements, Kaneka seeks to manage legal and disclosure risk and frame investor interpretation of the disclosed figures and guidance.

The most recent analyst rating on (JP:4118) stock is a Buy with a Yen5552.00 price target. To see the full list of analyst forecasts on Kaneka stock, see the JP:4118 Stock Forecast page.

Kaneka Nears Upper Limit of Ongoing Share Buyback Program

Kaneka Corporation disclosed the latest status of its share repurchase program authorized by its board in May 2025 under Japan’s Companies Act and its Articles of Incorporation. Between January 1 and January 31, 2026, the company bought back 115,000 shares of common stock on the Tokyo Stock Exchange for a total of ¥529.3 million, as part of a larger authorization to repurchase up to 3 million shares or ¥12 billion through March 24, 2026. Cumulatively, as of January 31, 2026, Kaneka has repurchased 2,164,000 shares for approximately ¥9.28 billion, indicating substantial progress toward the upper limit of the program and signaling continued emphasis on shareholder returns and capital efficiency.

The most recent analyst rating on (JP:4118) stock is a Hold with a Yen5079.00 price target. To see the full list of analyst forecasts on Kaneka stock, see the JP:4118 Stock Forecast page.

Kaneka Advances Share Repurchase Program, Buys Back 2.05 Million Shares to Date

Kaneka Corporation reported progress on its ongoing share repurchase program authorized by its board in May 2025, detailing that it bought back 135,100 shares of common stock on the Tokyo Stock Exchange between December 1 and December 31, 2025 for a total of ¥584.9 million. This transaction forms part of a larger buyback authorization of up to 3 million shares, or 4.77% of outstanding shares excluding treasury stock, and up to ¥12 billion through March 24, 2026, under which the company has cumulatively repurchased 2,049,000 shares for approximately ¥8.75 billion as of December 31, 2025, signaling an active capital return policy and potential support for shareholder value through reduced share float.

The most recent analyst rating on (JP:4118) stock is a Buy with a Yen4769.00 price target. To see the full list of analyst forecasts on Kaneka stock, see the JP:4118 Stock Forecast page.